Literature DB >> 24900799

Inhibitors of factor d may provide a treatment for age-related macular degeneration.

Ahmed F Abdel-Magid1.   

Abstract

Year:  2014        PMID： 24900799      PMCID： PMC4027787          DOI： 10.1021/ml500037a

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

1.  Activation of the alternative complement pathway in vitreous is controlled by genetics in age-related macular degeneration.

Authors:  Kelly M Loyet; Laura E Deforge; Kenneth J Katschke; Lauri Diehl; Robert R Graham; Lily Pao; Lizette Sturgeon; Sock-Cheng Lewin-Koh; Joe G Hollyfield; Menno van Lookeren Campagne
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-25       Impact factor: 4.799

2.  Decreased membrane complement regulators in the retinal pigmented epithelium contributes to age-related macular degeneration.

Authors:  Katayoon B Ebrahimi; Natalia Fijalkowski; Marisol Cano; James T Handa
Journal:  J Pathol       Date:  2013-01-24       Impact factor: 7.996

3.  Complement factor D in age-related macular degeneration.

Authors:  Chloe M Stanton; John R W Yates; Anneke I den Hollander; Johanna M Seddon; Anand Swaroop; Dwight Stambolian; Sascha Fauser; Carel Hoyng; Yi Yu; Kanda Atsuhiro; Kari Branham; Mohammad Othman; Wei Chen; Elod Kortvely; Kevin Chalmers; Caroline Hayward; Anthony T Moore; Baljean Dhillon; Marius Ueffing; Alan F Wright
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-11       Impact factor: 4.799
  3 in total
  2 in total

Review 1.  The role of the complement system in Multiple Sclerosis: A review.

Authors:  Nil Saez-Calveras; Olaf Stuve
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786

Review 2.  Complement, a target for therapy in inflammatory and degenerative diseases.

Authors:  B Paul Morgan; Claire L Harris
Journal:  Nat Rev Drug Discov       Date:  2015-10-23       Impact factor: 112.288
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.